Safety and Efficacy of Radiotherapy Combined with Immunotherapy for Advanced Malignant Tumors.

Summary

The goal of this clinical trial is to find a new radioimmunotherapy regimen for advanced malignancies with multiple metastatic after standard treatment failure/drug resistance. The main questions it aims to answer is: the safety and efficacy of the new regimen for advanced multiple metastatic solid tumors standard treatment failure/drug resistance, and explore the impact on immune function. Participants will receive the combination of radiotherapy and immunotherapy.

Timeline

Start

2025-08-01

Primary completion

2026-07-31

Completion

2026-12-31

Drugs

Indications